IL-20 and IL-20R1 antibodies protect against liver fibrosis

Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression

(2013) Chung-Hsi Hsing et al.   PLoS One

Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss

(2011) Yu-Hsiang Hsu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis

(2010) Yu-Hsiang Hsu et al.   ARTHRITIS AND RHEUMATISM

Protective effects of silica hydride against carbon tetrachloride-induced hepatotoxicity in mice

(2010) Yu-Wen Hsu et al.   FOOD AND CHEMICAL TOXICOLOGY

Bile Acid-induced Epidermal Growth Factor Receptor Activation in Quiescent Rat Hepatic Stellate Cells Can Trigger Both Proliferation and Apoptosis

(2009) Annika Sommerfeld et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke

(2009) W.-Y. Chen et al.   JOURNAL OF IMMUNOLOGY

Immune cell-mediated liver injury

(2009) Nadia Corazza et al.   Seminars in Immunopathology

Liver Transplantation: The Current Situation

(2009) Rene Adam et al.   SEMINARS IN LIVER DISEASE

Interleukin-20 targets renal cells and is associated with chronic kidney disease

(2008) Chi-Chen Wei et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis

(2008) Hsing-Hui Li et al.   CLINICAL IMMUNOLOGY

Mechanisms of Hepatic Fibrogenesis

(2008) Scott L. Friedman   GASTROENTEROLOGY

Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure

(2008) H-H Li et al.   GENES AND IMMUNITY